Legal Representation
Attorney
Julie Albert
USPTO Deadlines
Next Deadline
116 days remaining
NOA E-Mailed - SOU Required
Due Date
April 14, 2026
Extension Available
Until October 14, 2026
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 14, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 19, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 19, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 13, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 15, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 13, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 13, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 13, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 28, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Dec 29, 2023 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 26, 2023 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 15, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Sep 15, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 15, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 15, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 15, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 15, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 11, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Apr 5, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 28, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 21, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 14, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 7, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 28, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 28, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 21, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 21, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 21, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| May 21, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 21, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 21, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 2, 2020 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 9, 2020 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 27, 2019 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Apr 8, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 26, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 26, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 26, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Feb 26, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 26, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 26, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 26, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 26, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Detailed Classifications
Class 035
Commercialization of pharmaceutical drugs, medical devices, and biotechnological products; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of hospitals, academic and research institutions, and biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
Class 036
Venture capital funding services to emerging and start-up companies in the medical and health care industry; intellectual property venture fund development and formation services for others
Class 042
Contract research organization support services to the medical, health care, pharmaceutical, biotechnology, and medical device industries in the form of scientific, technological and medical research services outsourced on a contract basis; development of biopharmaceuticals and biologic assays; preclinical research, clinical research, and pharmacovigilance services in the nature of pharmacological research and analysis
Additional Information
Design Mark
The mark consists of the literal element "TMC CRI" presented in stylized dark grey font. In between the letters "TMC" and the letters "CRI" is a vertical line formed by a series of dark blue and light blue rectangles.
Color Claim
The color(s) dark grey, light blue, and dark blue is/are claimed as a feature of the mark.
Pseudo Mark
TEXAS MEDICAL CENTER CRI
Classification
International Classes
035
036
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CRI"